AMERISAFE (AMSF) Set to Announce Quarterly Earnings on Wednesday

Key Points

• AMERISAFE is expected to report Q3 2026 results after market close on October 28, with analysts forecasting earnings of $0.49 per share on revenue of $84.72 million. The earnings call is scheduled for October 29 at 10:00 a.m. ET.
• In its previous quarter, AMERISAFE reported $0.44 EPS, missing the $0.52 consensus estimate, while revenue of $91.97 million exceeded expectations. Analysts project full-year EPS of $1.95 and next-year EPS of $1.93.
• Shares opened at $25.35, well below their 12-month high of $42.21. Analyst sentiment is mixed, with a consensus “Hold” rating and a $35.67 target price, while several firms recently lowered ratings or price targets.

AMERISAFE (NASDAQ:AMSF - Get Free Report) is expected to be releasing its Q3 2026 results after the market closes on Wednesday, October 28th. Analysts expect AMERISAFE to announce earnings of $0.49 per share and revenue of $84.72 million for the quarter. Parties can check the company's upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Thursday, October 29, 2026 at 10:00 AM ET.

AMERISAFE (NASDAQ:AMSF - Get Free Report) last released its earnings results on Tuesday, July 21st. The insurance provider reported $0.44 earnings per share for the quarter, missing analysts' consensus estimates of $0.52 by ($0.08). The firm had revenue of $91.97 million for the quarter, compared to analysts' expectations of $85.09 million. AMERISAFE had a net margin of 14.00% and a return on equity of 14.87%. On average, analysts expect AMERISAFE to post $1.95 EPS for the current fiscal year and $1.93 EPS for the next fiscal year.

AMERISAFE Stock Up 0.0%

NASDAQ AMSF opened at $25.35 on Wednesday. The business has a 50-day moving average price of $25.18 and a 200-day moving average price of $29.47. AMERISAFE has a twelve month low of $23.20 and a twelve month high of $42.21. The firm has a market cap of $469.99 million, a price-to-earnings ratio of 12.67 and a beta of 0.24.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the stock. Wall Street Zen lowered shares of AMERISAFE from a "hold" rating to a "sell" rating in a research report on Tuesday. Truist Financial lowered their price target on shares of AMERISAFE from $32.00 to $27.00 and set a "hold" rating for the company in a report on Tuesday, October 13th. Citizens Jmp dropped their price target on AMERISAFE from $42.00 to $40.00 and set a "market outperform" rating for the company in a research report on Monday, October 12th. Citigroup reissued a "market outperform" rating on shares of AMERISAFE in a research note on Monday, October 12th. Finally, Weiss Ratings cut AMERISAFE from a "hold (c-)" rating to a "sell (d+)" rating in a research note on Tuesday, July 28th. Two equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $35.67.

AMERISAFE Company Profile

AMERISAFE, Inc NASDAQ: AMSF is a specialty workers' compensation insurance company serving small and midsize employers in industries with elevated workplace risks. The company provides coverage designed to help businesses manage the costs associated with work-related injuries and occupational illnesses.

Its primary markets include construction, trucking, logging, agriculture, maritime operations, oil and gas, and other hazardous industries. In addition to insurance coverage, AMERISAFE emphasizes workplace safety, risk management, claims handling and return-to-work support to help policyholders reduce accidents and manage employee injuries.

Headquartered in DeRidder, Louisiana, AMERISAFE has historically focused on selected U.S.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.